EDEG 2022 - PROGRAMME

zoom

Preliminary Program

Central European Summer Time (CEST)


Saturday 2nd April 2022

14:00 – 15:00 Registration

15:00 - 15:15 Welcome address

Chair EDEG Steering Committee: DORTE VISTISEN

Chair of the local organizing committee: STAVROS LIATIS

Professor Emeritus of Medicine, National and Kapodistrian University of Athens:NIKOLAOS KATSILAMPROS

15:15 - 16:00 Plenary Session 1 - Cardiovascular outcomes trials in diabetes: the idolatry of the subgroup?

Prof. APOSTOLOS TSAPAS

Chairs : DORTE VISTISEN , STAVROS LIATIS

16:00 - 17:00 Oral Presentations Session I - COVID-19 DISEASE AND DIABETES

Chairs : MARIT EIKA JØRGENSEN

THE CLINICAL COURSE OF COVID-19 IN DIABETES PATIENTS- A
NATION-WIDE MULTISTATE MODELLING COHORT STUDY
Hanan Amadid, Steno Diabetes Center Copenhagen, Denmark

INCIDENCE OF TYPE 1 DIABETES AFTER SARS-CoV-2 INFECTION IN 123 382 CHILDREN
German Tapia, Norwegian Institute of Public Health, Norway

RELATIONSHIP BETWEEN DIABETES AND SEVERE FORMS OF COVID-19 IN HOSPITALIZED PATIENTS: THE CORONADO
CASE-CONTROL STUDY
Matthieu Wargny, Nantes University Hospital, France

HAS THE COVID-19 PANDEMIC AFFECTED THE INCIDENCE OF TYPE 1 DIABETES? DATA FROM THE POPULATION-BASED
REGISTRY OF MARCHE REGION, ITALY
Rosaria Gesuita, Centre of Epidemiology and Biostatistics, Polytechnic University of Marche, Italy

17:00 - 17:30 Coffee break

17:30 - 18:30 Oral presentations, session II - DIABETES AND COMORBID FACTORS

Chairs : DANIEL WITTE

A NATIONWIDE STUDY OF THE EFFECTIVENESS OF DETECTING COLORECTAL CANCER WHEN IMPLEMENTING COLORECTAL
CANCER SCREENING IN INDIVIDUALS WITH DIABETES
Tinne Laurberg, Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark

EFFECT OF COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA ON METABOLIC OUTCOMES IN PEOPLE WITH TYPE 2
DIABETES AND INSOMNIA COMPARED TO CARE AS USUAL: A RANDOMIZED CONTROLLED TRIAL
Lenka Groeneveld, Amsterdam UMC, location VUmc, The Netherlands

QUALITY OF DIABETES CARE IN PEOPLE WITH AND WITHOUT PRIOR HOSPITALIZATION FOR SERIOUS MENTAL ILLNESS: A
SCOTTISH NATIONWIDE STUDY
Stine Scheuer, Steno Diabetes Center Copenhagen, Denmark

QUALITY OF DIABETES CARE AMONG PERSONS WITH TYPE 2 DIABETES WITH AND WITHOUT SEVERE MENTAL ILLNESS
Lenette Knudsen, Steno Diabetes Center Copenhagen, Denmark

18.30-19.00 EDEG Business meeting - General assembly

Chair : DORTE VISTISEN

19.00-20.00 Poster session I - DIABETES IN THE YOUNG AGE

Chairs : RASMUS CHRISTENSEN

THE PRESENCE AND EXTENT OF MICROVASCULAR DISEASE IS INDEPENDENTLY
ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 1 DIABETES.
Aikaterini Barmpagianni, First Department of Propaedeutic Medicine, Laiko General Hospital, Medical
School, National and Kapodistrian University of Athens, Greece

EXTRA SMALL HDL PARTICLE CONCENTRATION PREDICTS INCIDENT ISCHEMIC STROKE IN TYPE 1 DIABETES
Tina Costacou, University of Pittsburgh, USA

VITAMIN A CONSUMPTION IN PREGNANCY AND RISK OF OFFSPRING TYPE 1 DIABETES
Nicolai A. Lund-Blix, Norwegian Institute of Public Health, Norway

EFFECTS OF PUMP TREATMENT ON ENDOTHELIAL GLYCOCALYX AND CARDIOVASCULAR FUNCTION COMPARED TO MULTIPLE
DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 1 DIABETES: IMPROVEMENT AFTER A SIX-MONTH TREATMENT.
Aikaterini Kountouri, General University Attikon Hospital, Greece

FERTILITY AMONG WOMEN WITH TYPE 1 OR TYPE 2 DIABETES
Gunnar Toft, Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark

ASSOCIATIONS OF BIRTH WEIGHT WITH BODY COMPOSITION AND CARDIOMETABOLIC RISK
MARKERS IN CHILDREN AGED 8-12 YEARS: THE IABC STUDY"
Soboka Megersa Bikila, University of Copenhagen, Denmark

20:00 Welcome dinner



Sunday 3rd April 2022

11:45 - 13:15 Oral presentations, session III - DIABETES INCIDENCE

Chair : SARAH WILD

DIFFERENTIAL IMPACT OF FAMILY HISTORY OF TYPE 1 DIABETES ON INCIDENCE
OF ISLET AUTOIMMUNITY AND PROGRESSION TO CLINICAL TYPE 1 DIABETES: THE MIDIA STUDY
Lars C. Stene, Norwegian Institute of Public Health, Norway

LOW BIRTH WEIGHT IS ASSOCIATED WITH A NON-GENETIC HIGHER INCIDENCE RATE OF TYPE 2 DIABETES
Rasmus Wibaek, Steno Diabetes Center Copenhagen, Denmark

MATERNAL SMOKING DURING PREGNANCY AND TYPE 1 DIABETES IN THE OFFSPRING: A NATIONWIDE REGISTER-BASED
STUDY WITH FAMILY-BASED DESIGNS
Yuxia Wei, Karolinska Institutet, Sweden

PLASMA IMMUNOGLOBULIN G N-GLYCOSYLATION PATTERNS ARE ASSOCIATED WITH INCIDENT TYPE 2 DIABETES AND
CARDIOVASCULAR DISEASE: EPIC-POTSDAM STUDY
Anna Birukov, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany

TRENDS IN TYPE 1 DIABETES INCIDENCE IN SCOTLAND BETWEEN 2006 AND 2019
Sarah Wild, University of Edinburgh, United Kingdom

INTERACTION BETWEEN DAIRY PRODUCT INTAKE OR PHOSPHOLIPID ODD CHAIN FATTY ACIDS AND GAD65 AUTOANTIBODIES
ON THE INCIDENCE OF ADULT-ONSET DIABETES
Anna-Maria Lampousi, Institute of Environmental Medicine, Karolinska Institutet, Sweden

13:15 Lunch

14.15-15.00 Plenary Session 2 - The scope for a precision medicine approach to the treatment of type 2 diabetes

Dr. JOHN DENNIS

Chair : MATTIAS SCHULZE, FRANCIS FINUCANE

15:00-16.15 Poster session II - DIABETES MANAGEMENT

Chair : INA DANQUAH

PATTERNS OF REFERRAL, PATIENT PATHWAYS AND CHANGES IN HBA1C IN
SPECIALIST CARE FOR PATIENTS WITH TYPE 2 DIABETES
Kjersti Nøkleby, University of Oslo, Norway

THE EFFECT OF THREE-MONTH TREATMENT WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS OR SODIUM-GLUCOSE
CONTRASPORTER-2 INHIBITORS ON ENDOTHELIAL AND VASCULAR FUNCTION IN PATIENTS WITH TYPE 2 DIABETES
MELLITUS AND STROKE.
Aikaterini Kountouri, General University Attikon Hospital, Greece

COMPARING DIABETES CARE OUTCOMES OF THE CENTRALLY ORGANIZED HOORN
DIABETES CARE SYSTEM WITH REGULAR CARE BY GENERAL PRACTITIONERS IN THE
NETHERLANDS
Marieke Blom, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam
Public Health research institute, The Netherlands

THE EFFECT OF COMBINED DULAGLUTIDE-DAPAGLIFLOZIN TREATMENT VS DPP4 INHIBITORS ON ARTERIAL STIFFNESS AND
ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Emmanouil Korakas, Second Department of Internal Medicine and Research Institute, Medical School,
Attikon University Hospital, National and Kapodistrian University of Athens, Greece

VALIDATION OF AN ANNOUNCED TELEOPHONE PILL COUNT COMPARED TO A HOME-VISIT PILL COUNT IN PEOPLE WITH TYPE 2 DIABETES OR CARDIOVASCULAR DISEASE
Marlous Langendoen-Gort, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam Public Health Research Institute, The Netherlands

THE DIABETES, MANAGEMENT AND TREATMENT (DIAMANT) COHORT: A DYNAMIC PROSPECTIVE
COHORT OF PATIENTS WITH DIABETES TREATED IN PRIMARY CARE IN THE NETHERLANDS"
Karin Swart, PHARMO Institute for Drug Outcomes Research, The Netherlands

A BAYESIAN SEMI-PARAMETRIC APPROACH TO HANDLE MISSING DATA WITH APPLICATION TO A TREATMENT SELECTION
MODEL IN TYPE 2 DIABETES
John Dennis, University of Exeter, United Kingdom

CARDIOMETABOLIC EFFECTS OF PHARMACEUTICAL TREATMENT FOR OBESITY: 3 MONTHS DATA FROM A PROSPECTIVE STUDY
OF NALTREXONE/BUPROPION VS. LIRAGLUTIDE 3 MG ADMINISTRATION IN PATIENTS WITH INCREASED BODY WEIGHT.
Georgia Argyrakopoulou, Diabetes and Obesity Unit, Athens Medical Center, Greece

PATIENT-REPORTED OUTCOME MEASURES FOR ASSESSING HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH TYPE 2
DIABETES: A SYSTEMATIC REVIEW
Femke Rutters, Department of Epidemiology & Biostatistics, Amsterdam University Medical Center, the Netherlands

16:15 - 16:45 Coffee break

16:45 - 18:15 Oral presentations, session IV - TREATMENT AND FOLLOW-UP OF DIABETES

Chairs : ALEXANDROS KOKKINOS

TRAJECTORIES OF CLINICAL CHARACTERISTICS, TREATMENT CHOICES, AND
COMPLICATIONS IN DATA-DRIVEN SUBGROUPS OF TYPE 2 DIABETES
Xinyu Li, University of Groningen, The Netherlands

STENO-2 IMPACT STUDY: DOES THE SUCCESS OF STENO-2 TRIAL LED TO A CHANGE IN CLINICAL PRACTICE IN
TREATING TYPE 2 DIABETES PATIENTS WITH MICROALBUMINURIA USING MULTIFACTORIAL PHARMACOLOGICAL
INTERVENTION?
Lam Opal Huang, Steno Diabetes Center Copenhagen, Denmark

SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS AS ADJUNCT THERAPY FOR TYPE 1 DIABETES AND THE BENEFIT ON
CARDIOVASCULAR AND RENAL DISEASE EVALUATED BY STENO RISK ENGINES
Elisabeth Buur Stougaard, Steno Diabetes Center Copenhagen, Denmark

FACTORS AFFECTING CONTINUOUS PARTICIPATION IN FOLLOW-UP EVALUATIONS DURING A
LIFESTYLE INTERVENTION PROGRAM TO PREVENT TYPE 2 DIABETES: THE FEEL4DIABETES- STUDY
Elias Kourpas, University of Delaware, USA

SETTING THE OPTIMAL SCREENING INTERVAL FOR DIABETIC RETINOPATHY USING AN INDIVIDUALIZED APPROACH
Lars Jorge Diaz, Steno Diabetes Center Copenhagen, Denmark

THE ASSOCIATION BETWEEN PRE-RAMADAN DIABETES EDUCATION AND METABOLIC PARAMETERS IN MUSLIMS WITH TYPE 2
DIABETES: A RETROSPECTIVE STUDY
Siham Bouchareb, Department of General Practice, Amsterdam Public Health research institute, Amsterdam
UMC, Vrije Universiteit Amsterdam, The Netherlands

18:15-19:15 Poster session III - DIABETES AND LIFESTYLE

Chair: KRISTINE FAERCH

ADHERENCE TO THE DUTCH HEALTHY DIET INDEX AND CHANGE IN GLYCEMIX
CONTROL AND CARDIOMETABOLIC MARKERS IN PEOPLE WITH TYPE 2 DIABETES
Joline Beulens, Amsterdam UMC, The Netherlands

PHYSICAL ACTIVITY AND DIASTOLIC DYSFUNCTION IN PEOPLE WITH TYPE 2 DIABETES
Anna Hoek, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology & Data Science, The Netherlands

CHANGES IN OBJECTIVELY MEASURED PHYSICAL ACTIVITY ENERGY EXPENDITURE DURING A STRUCTURED AEROBIC
EXERCISE INTERVENTION IN HEALTHY OLDER ADULTS: THE HERTFORDSHIRE PHYSICAL ACTIVITY TRIAL.
Francis Finucane, National University of Ireland Galway, Ireland

A COMPREHENSIVE LIFESTYLE INDEX AND ITS ASSOCIATIONS WITH DNA METHYLATION AND TYPE 2 DIABETES AMONG
GHANAIAN ADULTS UNDER TRANSITION: THE RODAM STUDY
Carol Abidha, Heidelberg Institute of Global Health, Heidelberg University Hospital, Germany

LOW-CARB, HIGH-FAT DIET AND ASSOCIATIONS WITH GLYCAEMIC CONTROL AND DIABETIC COMPLICATIONS AMONG
GHANAIANS: THE RODAM STUDY
Tracy B Osei, Heidelberg Institute of Global Health (HIGH), Faculty of Medicine and University
Hospital, Heidelberg University, Germany

SYSTEMATIC REVIEW OF DIET QUALITY SCORES INCLUDING DIET DIVERSITY IN RELATION TO TYPE 2 DIABETES AMONG
OTHER CHRONIC DISEASES AND MORTALITY IN HEALTHY ADULTS
Daniela Nickel, Department of Molecular Epidemiology, German Institute of Human Nutrition
Potsdam-Rehbruecke, Germany

THE INTERACTION BETWEEN THE COMMUNITY FOOD ENVIRONMENT AND COOKING SKILLS IN RELATION TO DIET-RELATED OUTCOMES
Noreen Siddiqui, Amsterdam UMC, location VUmc, The Netherlands

THE ASSOCIATION OF VITAL EXHAUSTION AND BURNOUT WITH THE METABOLIC SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
Sanne Kremers, Amsterdam University Medical Centre, location VU medical Centre, Department of
Epidemiology and Datascience, The Netherlands

THE ASSOCIATION BETWEEN SOCIAL JETLAG AND THE METABOLIC SYNDROME AND TYPE 2 DIABETES: A SYSTEMATIC
REVIEW AND META-ANALYSIS
Emma Bouman, Amsterdam UMC, The Netherlands

19:15 Dinner




Monday 4th April 2022

09.15-10.00 Plenary Session 3 - Diabetes Epidemiology in Practice

Prof. GIEL NIJPELS

Chairs : KONSTANTINOS MAKRILAKIS, FEMKE RUTTERS

10:00 - 11:00 Oral presentations, session V - BURDEN OF DIABETES AND ITS COMPLICATIONS

Chairs : MARIEKE BLOM

CLINICAL CHARACTERISTICS ASSOCIATED WITH SUDDEN CARDIAC ARREST IN
PEOPLE WITH TYPE 2 DIABETES: A CASE-CONTROL STUDY ON PRIMARY CARE DATA
Peter Harms, Amsterdam UMC, The Netherland

MEN WITH YOUNG ONSET TYPE 2 DIABETES DEVELOP RETINOPATHY AT AN EARLIER AGE AND SOONER AFTER DIAGNOSIS THAN WOMEN
Katrina Tibballs, Department of General Practice, Institute of Health and Society, Faculty of Medicine,
University of Oslo, Norway

CARDIOVASCULAR COMPLICATIONS IN TYPE 2 DIABETES BEFORE AND AFTER DIAGNOSIS: IMPACT ON EXPECTED LIFETIME
AND TRENDS 1996-2020.
Kim Katrine Bjerring Clemmensen, Steno Diabetes Center Copenhagen, Denmark

HUGE INCREASE IN DKA AND SEVERE DKA AT THE ONSET OF TYPE 1 DIABETES IN ITALY IN 2020: A SILENT EPIDEMIC
Valentino Cherubini, Department of Women’s and Children’s Health Azienda Ospedaliero-Universitaria,
Ospedali Riuniti di Ancona, Italy

11:00 - 11:30 Coffee break

11:00-13.00 Poster session IV - CARDIOMETABOLIC RISK AND INCIDENCE/PREVALENCE OF TYPE 2 DIABETES

Chairs : TINA COSTACOU

PLASMA INDUSTRIAL AND RUMINANT TRANS FATTY ACIDS AND INCIDENT TYPE 2 DIABETES IN THE EPIC-POTSDAM COHORT
Matthias Schulze Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany

GENDER DIFFERENCES IN SCREENING FOR GLUCOSE PERTURBATIONS, CARDIOVASCULAR RISK FACTOR MANAGEMENT, AND
PROGNOSIS IN PATIENTS WITH CORONARY ARTERY DISEASE AND DYSGLYCAEMIA.
Jaakko Tuomilehto, Finnish Institute for Health and Welfare, Finland

TRENDS IN THE PREVALENCE AND INCIDENCE OF PREDIABETES AMONG IMMIGRANTS IN ONTARIO, CANADA, 2011-2017
Ghazal Fazli, Unity Health Toronto, Canada

TYPE 2 DIABETES, THE EPIDEMIC: TRENDS IN PREVALENCE, TREATMENT AND RISK-FACTOR
CONTROL, 2004-2019
Jetty Overbeek, PHARMO Institute for Drug Outcomes Research, The Netherlands
PLASMA RETINOL AND RETINOL BINDING PROTEIN 4 LEVELS AND RISK OF CARDIOVASCULAR DIASEASES AND TYPE 2
DIABETES
Catarina Schiborn, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany

BODY MASS INDEX AND OBESITY: ACCURACY AND PREDICTION BASED ON SELF-REPORTED WEIGHT AND HEIGHT IN A
NATIONWIDE HEALTH EXAMINATION SURVEY IN GREECE
Nikos Pantazis, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine,
National and Kapodistrian University of Athens, Greece

THE ENTERO-ENDOCRINE RESPONSE FOLLOWING A MIXED-MEAL CHALLENGE WITH A NON-NUTRITIVE PRE-LOAD IN
PARTICIPANTS WITH PRE-DIABETES AND TYPE 2 DIABETES: A CROSSOVER RANDOMIZED CONTROLLED TRIAL
Mirthe Muilwijk, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology & Datascience, The Netherlands

OBESITY IN ADULTS LIVING IN GREECE: PREALENCE, FACTORS ASSOCIATED WITH AND ITS CONTRIBUTION TO
CARDIOVASCULAR RISK FACTORS’ CLUSTERING
Giota Touloumi, Dept. of Hygiene, Epidemiology & Medical Statistics, Medical School, National & Kapodistrian University of Athens, Greece

BODY MASS INDEX AND PREVALENCE OF OBESITY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. A COMPARISON OVER
THE LAST 20 YEARS.
Stamatia Simati, First Department of Propaedeutic Medicine, Diabetes Center, Laiko Hospital, Medical
School, National & Kapodistrian University of Athens, Greece

DIABETES MELLITUS TYPE 2 AND OTHER MODIFIABLE RISK FACTORS AMONG PATIENTS HOSPITALIZED
FOR ACUTE CORONARY SYNDROME IN A TERTIARY HOSPITAL DURING ONE-YEAR PERIOD.
Chris Siafarikas, Laiko General Hospital of Athens, Greece

PREDICTING SUDDEN CARDIAC DEATH IN THE GENERAL POPULATION:
VALIDATION OF A PREDICTION MODEL FOR THE OCCURRENCE OF SUDDEN CARDIAC DEATH IN THE GENERAL POPULATION:
THE ESCAPE-NET PROJECT
Sabrina Welten, Amsterdam Public Health research institute, The Netherlands

13:00 - 14.30 Lunch

14.30-15.15 Plenary Session 4 - Type 2 Diabetes in Youth

Prof. DANA DABELEA

Chairs : JEAN LAWRENCE, GREGERS STIG ANDERSEN

15.15 - 16.45 Oral presentations, session VI - PREDICTORS OF DIABETES

Chairs : GIOTA TOULOUMI

DNA METHYLATION MEDIATES THE RELATIONSHIP BETWEEN FAMILY HISTORY OF
TYPE 1 DIABETES (T1D) AND T1D RISK: THE DIABETES AUTOIMMUNITY STUDY IN THE YOUNG (DAISY)
Jill Norris, Colorado School of Public Health, USA

METABOLOMIC PREDICTORS OF DYSGLYCEMIA IN TWO YOUTH COHORTS: EXPLORING PERINATAL OUTCOMES AMONG CHILDREN
AND PROJECT VIVA
Wei Perng, Colorado School of Public Health, USA

ASSOCIATIONS BETWEEN PARENTAL BMI AND OFFSPRING BMI TRAJECTORIES-POTENTIAL EFFECT MODIFICATION BY
GRANDPARENTAL SOCIO-ECONOMIC POSITION
Jie Zhang, Aarhus University, Denmark

DOMAIN OF PHYSICAL ACTIVITY MATTERS FOR RISK OF TYPE 2 DIABETES
Jeroen van der Velde, Department of clinical epidemiology, Leiden University Medical Center, The Netherland

ASSOCIATIONS OF LONGITUDINAL CHANGES OF DIETARY PATTERNS AND RISK OF TYPE 2 DIABETES AND CARDIOVASCULAR
DISEASES IN THE EPIC-POTSDAM STUDY
Franziska Jannasch, Department of Molecular Epidemiology, German Institute of Human Nutrition
Potsdam-Rehbruecke (DIfE), Germany

INTERACTION BETWEEN TOBACCO USE AND TYPE 2 GENETIC SUSCEPTIBILITY IN THE RISK OF T2D AND LADA
Jessica Edstorp, Karolinska Institutet, Sweden

16.45-17.15 Coffee break

17.15-18.15 Poster session V - COMPLICATIONS OF DIABETES

Chairs : MIRTHE MUILWIJK

INTERLEUKIN 6 AND INCIDENT HEART FAILURE IN PERSONS WITH TYPE 2
DIABETES: THE HOORN DIABETES CARE SYSTEM COHOR
Sharon Remmelzwaal, Department of Epidemiology & Data Science, Amsterdam Public Health Research
Institute, Amsterdam Cardiovascular Sciences Research Institute, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands

DYSGLYCAEMIA IS ASSOCIATED WITH LOW BLOOD OXYGEN SATURATION IN INDIVIDUALS WITH AND WITHOUT DIABETES OR
PREDIABETES: A CROSS-SECTIONAL STUDY IN THE LOLLAND-FALSTER HEALTH STUDY COHORT
Jens Christian Laursen, Steno Diabetes Center Copenhagen, Denmark

DEVELOPMENT IN KIDNEY FUNCTION AMONG PEOPLE WITH DIABETES AND NEPHROPATHY: A RETROSPECTIVE COHORT STUDY
Kristin Jesse, Steno Diabetes Center Copenhagen, Denmark

INCIDENCE AND PREVALENCE OF DIABETIC RETINOPATHY IN THE GREENLANDIC INUIT: A REGISTER-BASED STUDY
Trine Jul Larsen, University of Greenland, Ilisimatusarfik, Nuuk, Greenland

EFFECT OF THE SECOND COVID-19-ASSOCIATED LOCKDOWN ON THE METABOLIC CONTROL OF PATIENTS WITH TYPE 2
DIABETES IN GREECE
Eleftheria Papachristoforou, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece

KIDNEY FUNCION AND RISK OF DEMENTIA: OBSERVATIONAL STUDY, META-ANALYSIS AND TWO-SAMPLE MENDELIAN
RANDOMIZATION STUDY
Daniel Witte, Steno Diabetes Center Aarhus, Denmark

SEX-DIFFERENCES IN DEPRESSIVE SYMPTOMS AND DIABETES IN MEXICO. FINDINGS FROM ENSANUT 2018-19
Omar Silverman-Retana, Aarhus University, Steno Diabetes Center Aarhus and Danish Diabetes Academy, Denmark

THE IMPACT OF COUNTRY OF BIRTH ON DEVELOPMENT OF DIABETIC LATE COMPLICATIONS IN YOUNGER ADULTS WITH
EARLY-ONSET TYPE 2 DIABETES: A REGISTRY-BASED STUDY
Kristine Stoltenberg Addington, Steno Diabetes Center Copenhagen, Denmark

18.15-18.45 Oral presentations VII - DIABETES PREVALENCE AND SUBTYPES

Chairs : JAAKKO TUOMILEHTO

PREVALENCE OF UNDIAGNOSED DIABETES IN POPULATION-BASED STUDIES BY
NATIONAL HEALTH AND ECONOMIC METRICS: A SYSTEMATIC REVIEW
Paz Lopez-Doriga Ruiz, Department of Chronic Diseases, Norwegian Institute of Public Health, Norway

NOVEL SUBGROUPS OF ADULT-ONSET DIABETES IN GHANAIAN POPULATIONS –
A DATA-DRIVEN CLUSTER ANALYSIS WITH CLINICAL VARIABLES
Ina Danquah, Heidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Germany

18.45-19.00 Closing remarks

KONSTANTINOS MAKRILAKIS, DORTE VISTISEN

19:30 Gala Dinner



Tuesday 5th April 2022

Check-out and departures


You can download the Scientific Program HERE